Jacobs Levy Equity Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Buy |
|
|||||
|
2025
Q1 | $353K | Sell |
|
|||||
|
2024
Q4 | $1.31M | Sell |
|
|||||
|
2024
Q3 | $1.71M | Sell |
|
|||||
|
2024
Q2 | $1.87M | Sell |
|
|||||
|
2024
Q1 | $2.72M | Buy |
|
|||||
|
2023
Q4 | $1.68M | Sell |
|
|||||
|
2023
Q3 | $1.66M | Sell |
|
|||||
|
2023
Q2 | $2.11M | Sell |
|
|||||
|
2023
Q1 | $2.12M | Buy |
|
|||||
|
2022
Q4 | $2.4M | Buy |
|
|||||
|
2022
Q3 | $2.17M | Sell |
|
|||||
|
2022
Q2 | $3.07M | Buy |
|
|||||
|
2022
Q1 | $1.11M | Buy |
|